Journal of Clinical Healthcare (JCHC)

23-27 27 Journal of Clinical Healthcare 2/2018 adolescents: a systematic review of population-based studies. Dev Med Child Neurol 2010;52:1088–97. 17. Berg J, Stovner LJ. Cost of migraine and other head- aches in Europe. Eur J Neurol 2005;12(Suppl 1): 59– 62. 18. Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol 2008; 7:354–61. 19. Lifting the Burden: The Global Campaign against Headache. Available at: www.l-t-b.org. 20. Lipton R, Stewart W, Diamond S, Diamond M, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001;41:646–57 21. Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R. Prognosis of migraine and tension-type headache: a population-based follow-up study. Neurology 2005;65:580–585. 22. Merikangas KR, Lateef T. Epidemiology and quality of life of migraine. In: Fernández-de-las-Peñas C, Chaitow L, Schoenen J, editors. Multidisciplinary man- agement of migraine: pharmacological, manual and other therapies. Sudbury: Jones & Bartlett Learning, 2017. 23. Karbowniczek A, Domitrz I. Przewlekły codzienny ból głowy wśród pacjentów poradni bólów głowy: częstość występowania i obraz kliniczny. Neurol Neuroch Pol 2011;45(1):11-17. 24. Juang K-D, Wang S-J, Fuh J-L, et al . Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache 2000;40:818- 823. 25. Diener HC, Katsarava Z, Limmroth V. Headache at- tributed to a substance or its withdrawal. Hand Clin Neurol 2010;97:589-599. 26. Jinap S., Hajeb P. Glutamate. Its applications in food and contribution to health. Appetite 2010;55(1):1-10. 27. Freeman M. Reconsidering the effects of monosodium glutamate: a literature review. J AM Acd Nurse Pract 2006;18(10):482-486. 28. Yokoyama M, Suzuki N, Yokoyama T, et al . Interac- tions between migraine and tension-type headache and alcohol drinking, alcohol flushing, and hangover in Japanese. J Headache Pain 2012:13:137-145. 29. Schep LJ, Slaughter RJ, Vale JA, et al . The clinical toxicology of the designer „part pills” benzylpiperazine and trifluoromethylphenylpiperazine. Clin Toxicol 2011;49(3):131-141.